Pharmaceutical companies such as Valeant are buying drugs that they see as undervalued, then raising the prices.
Fitch downgrades Japan’s credit rating, highlighting the challenges Prime Minister Shinzo Abe faces in trying to stoke growth and rein in public debt.
Israel “Izzy” Englander’s Millennium Management and quant trader Igor Tulchinsky plan a joint venture that will allow the trader to accept outside money.
Japan’s Nikkei hitting a 15-year high isn’t a reason not to buy into the rally. But it is time for Japan investors to become more discerning.
European stocks fell after the deadlock in negotiations over unlocking further financial aid for Greece kept markets on edge.
The suggestion by some officials reflects the extent to which many of the eurozone’s decision makers no longer believe a deal on new bailout aid for Athens can be sealed before the old one expires.
Ferdinand Piech’s exit as chairman of Volkswagen resolves a battle that had distracted top management. But challenges and uncertainty aren't over for the automotive giant.
Applied Materials and Tokyo Electron said that they will scrap plans to merge their operations, citing problems with the U.S. Justice Department.
Deutsche Bank released details of its plan to boost profitability and capital adequacy.
When Prime Minister Shinzo Abe visits the U.S., he will act as salesman-in-chief by marketing Japan’s high-speed rail system.